US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
DK1137789T3
(da)
|
1998-12-09 |
2010-11-08 |
Phyton Holdings Llc |
Fremgangsmåde til fremstilling af et glycoprotein med glycosylering af human type
|
NZ518532A
(en)
|
1999-10-26 |
2004-02-27 |
Plant Res Internat B |
Transgenic plant expressing mammalian beta-1,4- galactosyltransferase
|
US7198921B2
(en)
*
|
2000-05-17 |
2007-04-03 |
Mitsubishi Pharma Corporation |
Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US7795002B2
(en)
|
2000-06-28 |
2010-09-14 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
US20060024304A1
(en)
*
|
2000-06-28 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
|
US20060034828A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
US20060029604A1
(en)
*
|
2000-06-28 |
2006-02-09 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US20060034830A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
|
EP2322644A1
(de)
*
|
2000-06-28 |
2011-05-18 |
GlycoFi, Inc. |
Verfahren für die Herstellung modifizierter Glykoproteine
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US8697394B2
(en)
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
EP1294910B1
(de)
|
2000-06-30 |
2008-11-19 |
VIB vzw |
Modifikation der proteinglycosylierung in pichia pastoris
|
WO2002051438A2
(en)
|
2000-12-22 |
2002-07-04 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
CN100385006C
(zh)
|
2001-01-19 |
2008-04-30 |
陶氏化学公司 |
利用植物细胞分泌性生产具有人型糖链的糖蛋白的方法
|
TWI377253B
(en)
|
2001-04-16 |
2012-11-21 |
Martek Biosciences Corp |
Product and process for transformation of thraustochytriales microorganisms
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
US7439043B2
(en)
*
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
US7226903B2
(en)
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
DK1578771T3
(da)
*
|
2001-10-10 |
2013-06-10 |
Novo Nordisk As |
Remodellering og glycokonjugering af peptider
|
US7157277B2
(en)
*
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US8008252B2
(en)
*
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7265084B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
EP2322229B1
(de)
|
2001-10-10 |
2016-12-21 |
Novo Nordisk A/S |
Neumodulierung und Glykokonjugation von Faktor IX
|
US7265085B2
(en)
*
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
US20060024292A1
(en)
*
|
2001-12-27 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
|
MXPA04006357A
(es)
|
2001-12-27 |
2005-03-31 |
Glycofi Inc |
Metodos para disenar estructuras de carbohidrato del tipo de mamifero.
|
US20060034829A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
|
US6964784B2
(en)
*
|
2002-03-07 |
2005-11-15 |
Optigenex, Inc. |
Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
|
AU2003219418B2
(en)
*
|
2002-03-19 |
2008-02-28 |
Stichting Dienst Landbouwkundig Onderzoek |
Optimizing glycan processing in plants
|
NZ546945A
(en)
|
2002-03-19 |
2008-04-30 |
Plant Res Int Bv |
A plant host cell system for the expression of human GnTIII
|
US7972809B2
(en)
|
2002-04-26 |
2011-07-05 |
National Institute Of Advanced Industrial Science & Technology |
Methylotrophic yeast producing mammalian type sugar chain
|
MXPA04012496A
(es)
|
2002-06-21 |
2005-09-12 |
Novo Nordisk Healthcare Ag |
Glicoformos del factor vii pegilados.
|
US7252933B2
(en)
*
|
2002-06-26 |
2007-08-07 |
Flanders Interuniversity Institute For Biotechnology |
Protein glycosylation modification in methylotrophic yeast
|
KR20040004089A
(ko)
*
|
2002-06-29 |
2004-01-13 |
한국생명공학연구원 |
당외쇄 합성 결손 한세눌라 폴리모르파 변이주 및 그를이용한 재조합 당단백질의 제조 방법
|
AU2003263717A1
(en)
*
|
2002-09-25 |
2004-04-19 |
Astrazeneca Ab |
A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
|
AR042145A1
(es)
|
2002-11-27 |
2005-06-08 |
Dow Agrociences Llc |
Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
|
RU2407796C2
(ru)
*
|
2003-01-22 |
2010-12-27 |
Гликарт Биотекнолоджи АГ |
КОНСТРУКЦИИ СЛИЯНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ АНТИТЕЛ С ПОВЫШЕННЫМИ АФФИННОСТЬЮ СВЯЗЫВАНИЯ Fc-РЕЦЕПТОРА И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ
|
PL222219B1
(pl)
|
2003-01-22 |
2016-07-29 |
Glycart Biotechnology Ag |
Komórka gospodarza i sposób wytwarzania polipeptydu w komórce gospodarza
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
AU2012227297B2
(en)
*
|
2003-02-20 |
2013-11-14 |
Glycofi, Inc. |
Combinatorial DNA Library for Producing Modified N-Glycans in Lower Eukaryotes
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
NZ542094A
(en)
|
2003-03-14 |
2008-12-24 |
Neose Technologies Inc |
Branched polymer conjugates comprising a peptide and water-soluble polymer chains
|
US7691603B2
(en)
*
|
2003-04-09 |
2010-04-06 |
Novo Nordisk A/S |
Intracellular formation of peptide conjugates
|
SG155777A1
(en)
|
2003-04-09 |
2009-10-29 |
Neose Technologies Inc |
Glycopegylation methods and proteins/peptides produced by the methods
|
WO2007022512A2
(en)
*
|
2005-08-19 |
2007-02-22 |
Neose Technologies, Inc. |
Glycopegylated factor vii and factor viia
|
WO2006127896A2
(en)
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
EP1624847B1
(de)
|
2003-05-09 |
2012-01-04 |
BioGeneriX AG |
Zusammensetzungen und Verfahren zur Herstellung von Glykosylierungsmutanten des menschlichen Wachstumshormons
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
US9357755B2
(en)
*
|
2003-10-28 |
2016-06-07 |
The University Of Wyoming |
Production of human glycosylated proteins in silk worm
|
US20070067855A1
(en)
*
|
2003-10-28 |
2007-03-22 |
Chesapeake Perl, Inc. |
Production of human glycosylated proteins in transgenic insects
|
US20050100965A1
(en)
|
2003-11-12 |
2005-05-12 |
Tariq Ghayur |
IL-18 binding proteins
|
US7507573B2
(en)
|
2003-11-14 |
2009-03-24 |
Vib, Vzw |
Modification of protein glycosylation in methylotrophic yeast
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US7405198B2
(en)
*
|
2003-11-24 |
2008-07-29 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20080318850A1
(en)
*
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
AU2004311545B2
(en)
*
|
2003-12-24 |
2008-11-06 |
Glycofi, Inc. |
Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins
|
EP1765853B1
(de)
|
2004-01-08 |
2015-10-28 |
ratiopharm GmbH |
O-Glykosylierung von G-CSF Peptiden
|
KR100604994B1
(ko)
*
|
2004-01-30 |
2006-07-26 |
한국생명공학연구원 |
알파1,6-만노실트랜스퍼라제를 코딩하는 한세눌라폴리모르파 기원의 신규 유전자 및 상기 유전자가 결손된한세눌라 폴리모르파 변이주를 이용한 재조합 당단백질생산 방법
|
WO2005090552A2
(en)
*
|
2004-03-17 |
2005-09-29 |
Glycofi, Inc. |
Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
|
WO2005089047A2
(en)
*
|
2004-03-18 |
2005-09-29 |
Glycofi, Inc. |
Glycosylated glucocerebrosidase expression in fungal hosts
|
CA2562772A1
(en)
*
|
2004-04-15 |
2005-10-27 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
JP5752582B2
(ja)
*
|
2004-04-29 |
2015-07-22 |
グライコフィ, インコーポレイテッド |
糖タンパク質の作製においてアルファ−マンノシダーゼ抵抗性グリカンを減少させるか又は排除する方法
|
AU2005238308B8
(en)
*
|
2004-04-29 |
2009-10-08 |
Glycofi, Inc. |
Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins
|
RU2006138181A
(ru)
*
|
2004-05-04 |
2008-06-10 |
Ново Нордиск Хелс Кеа Аг (Ch) |
О-связанные гликоформы полипептидов и способ их изготовления
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
JP2008512355A
(ja)
*
|
2004-07-21 |
2008-04-24 |
グライコフィ, インコーポレイテッド |
GlcNAcMan5Man3GlcNAc2グリコフォームを支配的に含む免疫グロブリン
|
WO2006026992A1
(en)
*
|
2004-09-07 |
2006-03-16 |
Novozymes A/S |
Altered structure of n-glycans in a fungus
|
WO2006031811A2
(en)
|
2004-09-10 |
2006-03-23 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
US20080108557A1
(en)
*
|
2004-09-29 |
2008-05-08 |
Novo Nordisk Healthcare A/G |
Modified Proteins
|
EP3061461A1
(de)
|
2004-10-29 |
2016-08-31 |
ratiopharm GmbH |
Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
|
WO2006071856A2
(en)
*
|
2004-12-23 |
2006-07-06 |
Glycofi, Inc. |
Immunoglobulins comprising predominantly a man5glcnac2 glycoform
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
DE602006011132D1
(en)
*
|
2005-03-07 |
2010-01-28 |
Plant Res Int Bv |
Glycoengineering in pilzen
|
WO2006105426A2
(en)
*
|
2005-03-30 |
2006-10-05 |
Neose Technologies, Inc. |
Manufacturing process for the production of peptides grown in insect cell lines
|
WO2006121569A2
(en)
*
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
US7700739B2
(en)
*
|
2005-06-30 |
2010-04-20 |
Abbott Laboratories |
IL-12/p40 binding proteins
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
US20090215992A1
(en)
*
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
CN101370525B
(zh)
|
2005-08-19 |
2013-09-18 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
EP2500359A3
(de)
|
2005-08-19 |
2012-10-17 |
Abbott Laboratories |
Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung
|
WO2007028144A2
(en)
*
|
2005-09-02 |
2007-03-08 |
Glycofi, Inc |
Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform
|
AU2005336263A1
(en)
*
|
2005-09-09 |
2007-03-15 |
Glycofi, Inc. |
Immunoglobulin comprising predominantly a man7GlcNAc2, Man8GlcNAc2 glycoform
|
CA2623197A1
(en)
*
|
2005-09-22 |
2007-03-29 |
Prosci Incorporated |
Glycosylated polypeptides produced in yeast mutants and methods of use thereof
|
ES2542501T3
(es)
|
2005-09-30 |
2015-08-06 |
Abbvie Deutschland Gmbh & Co Kg |
Dominios de unión de proteínas de la familia de proteínas de moléculas de orientación repulsiva (RGM) y fragmentos funcionales de las mismas, así como su uso
|
KR101105718B1
(ko)
|
2005-10-27 |
2012-01-17 |
한국생명공학연구원 |
돌리칠 포스페이트 만노스 의존알파-1,3-만노실트랜스퍼라제를 코딩하는 한세눌라폴리모르파 기원의 신규 유전자와 상기 유전자가 결손된한세눌라 폴리모르파 변이주를 이용한 재조합 당단백질생산 방법
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
EP1954815B1
(de)
*
|
2005-11-15 |
2015-02-25 |
GlycoFi, Inc. |
Herstellung von glycoproteinen mit reduzierter o-glycosylierung
|
CN102898519B
(zh)
|
2005-11-30 |
2015-10-28 |
Abbvie公司 |
抗淀粉样β蛋白的单克隆抗体及其用途
|
EP2289909B1
(de)
|
2005-11-30 |
2014-10-29 |
AbbVie Inc. |
Screeningsverfahren, Verfahren zur Reinigung von nicht-diffundierenden Beta-Oligomeren, selektive Antikörper gegen genannten nichtdiffundierende Beta-Oligomere und Verfahren zur Herstellung von genannten Antikörpern
|
US7884264B2
(en)
*
|
2006-01-17 |
2011-02-08 |
Biolex Therapeutics, Inc. |
Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants
|
US20090060921A1
(en)
*
|
2006-01-17 |
2009-03-05 |
Biolex Therapeutics, Inc. |
Glycan-optimized anti-cd20 antibodies
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
US20090181041A1
(en)
*
|
2006-01-23 |
2009-07-16 |
Jan Holgersson |
Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
|
EP2264061A1
(de)
*
|
2006-01-26 |
2010-12-22 |
Recopharma AB |
Zusammensetzung und verfahren zur Bekämpfung von viralen Infektionen
|
US20110104750A1
(en)
*
|
2006-04-05 |
2011-05-05 |
Michael Ward |
Filamentous Fungi Having Reduced UDP-Galactofuranose Content
|
MX2008013394A
(es)
*
|
2006-04-21 |
2008-10-31 |
Wyeth Corp |
Metodos para tamizado de alta emision de lineas celulares.
|
JP5424871B2
(ja)
*
|
2006-05-19 |
2014-02-26 |
グライコフィ, インコーポレイテッド |
組換えベクター
|
MX2008014744A
(es)
*
|
2006-05-19 |
2009-02-10 |
Glycofi Inc |
Composiciones de eritrocpoyetina.
|
ATE516346T1
(de)
*
|
2006-05-24 |
2011-07-15 |
Univ Provence Aix Marseille 1 |
Herstellung und verwendungen von chimäre glykosyltransferasen mit optimierter glykosylierungsaktivität codierenden gensequenzen
|
AR078117A1
(es)
|
2006-06-20 |
2011-10-19 |
Protech Pharma S A |
Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina
|
US20080274958A1
(en)
*
|
2006-07-21 |
2008-11-06 |
Neose Technologies, Inc. |
Glycosylation of peptides via o-linked glycosylation sequences
|
US7879799B2
(en)
*
|
2006-08-10 |
2011-02-01 |
Institute For Systems Biology |
Methods for characterizing glycoproteins and generating antibodies for same
|
HUE052220T2
(hu)
|
2006-09-08 |
2021-04-28 |
Abbvie Bahamas Ltd |
Interleukin-13 kötõfehérjék
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
CA2665644A1
(en)
*
|
2006-10-12 |
2008-05-29 |
Genentech, Inc. |
Antibodies to lymphotoxin-alpha
|
EP1916259A1
(de)
|
2006-10-26 |
2008-04-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Anti-Glycoprotein VI SCFV Fragment zur Thrombosebehandlung
|
WO2008073620A2
(en)
*
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
TW200833711A
(en)
*
|
2006-12-22 |
2008-08-16 |
Genentech Inc |
Antibodies to insulin-like growth factor receptor
|
FR2912154B1
(fr)
|
2007-02-02 |
2012-11-02 |
Glycode |
Levures genetiquement modifiees pour la production de glycoproteines homogenes
|
DK2148691T3
(en)
|
2007-02-05 |
2015-08-17 |
Apellis Pharmaceuticals Inc |
Compstatinanaloger for use in the treatment of inflammatory states of the respiratory system
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
CN101679934B
(zh)
|
2007-03-07 |
2014-04-02 |
格利科菲公司 |
具有经修饰的岩藻糖基化的糖蛋白的生产
|
WO2008112192A2
(en)
|
2007-03-08 |
2008-09-18 |
Kalobios Pharmaceuticals, Inc. |
Epha3 antibodies for the treatment of solid tumors
|
MX2009010120A
(es)
|
2007-03-22 |
2009-10-19 |
Ucb Pharma Sa |
Proteinas de union, incluyendo anticuerpos, derivados de anticuerpo y fragmentos de anticuerpo, que se unen especificamente cd154 y sus usos.
|
CA2682578C
(en)
|
2007-04-03 |
2015-05-26 |
Oxyrane Uk Limited |
Glycosylation of molecules
|
NZ580030A
(en)
|
2007-04-03 |
2012-06-29 |
Biogenerix Ag |
Methods of treatment using glycopegylated g-csf
|
US20080256056A1
(en)
*
|
2007-04-10 |
2008-10-16 |
Yahoo! Inc. |
System for building a data structure representing a network of users and advertisers
|
NZ580510A
(en)
|
2007-04-17 |
2011-06-30 |
Stichting Dienst Landbouwkundi |
Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
|
EP2703011A3
(de)
|
2007-05-07 |
2014-03-26 |
MedImmune, LLC |
Anti-Icos-Antikörper und ihre Verwendung bei der Behandlung von Krebs, Transplantationen und Autoimmunerkrankungen
|
WO2008143878A1
(en)
|
2007-05-14 |
2008-11-27 |
Medimmune, Llc |
Methods of reducing eosinophil levels
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
US20090232801A1
(en)
*
|
2007-05-30 |
2009-09-17 |
Abbot Laboratories |
Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
|
PE20090329A1
(es)
*
|
2007-05-30 |
2009-03-27 |
Abbott Lab |
Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
US8637435B2
(en)
*
|
2007-11-16 |
2014-01-28 |
Merck Sharp & Dohme Corp. |
Eukaryotic cell display systems
|
SG10201406572TA
(en)
|
2007-12-19 |
2014-11-27 |
Glycofi Inc |
Yeast strains for protein production
|
EP2240595B2
(de)
*
|
2008-01-03 |
2019-07-24 |
Cornell Research Foundation, Inc. |
Expression eines glycosylierten proteins in prokaryonten
|
EP2245151B1
(de)
*
|
2008-02-20 |
2014-12-24 |
GlycoFi, Inc. |
Vektoren und hefestämme für die proteinproduktion
|
KR101582841B1
(ko)
|
2008-02-27 |
2016-01-11 |
노보 노르디스크 에이/에스 |
콘쥬게이트된 인자 viii 분자
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
WO2009111183A1
(en)
|
2008-03-03 |
2009-09-11 |
Glycofi, Inc. |
Surface display of recombinant proteins in lower eukaryotes
|
CA2717614A1
(en)
*
|
2008-03-11 |
2009-09-17 |
Genentech, Inc. |
Antibodies with enhanced adcc function
|
SG190572A1
(en)
|
2008-04-29 |
2013-06-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
PT2439212T
(pt)
|
2008-05-02 |
2017-03-29 |
Novartis Ag |
Moléculas de ligação baseadas em fibronectina melhoradas e suas utilizações
|
JP5890174B2
(ja)
|
2008-05-09 |
2016-03-22 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
終末糖化産物受容体(rage)に対する抗体及びその使用
|
MX2010013059A
(es)
*
|
2008-05-30 |
2010-12-20 |
Glycofi Inc |
Cepa de levadura para la produccion de proteinas con galactosa alfa-1,3-enlazada terminal.
|
RU2010153580A
(ru)
|
2008-06-03 |
2012-07-20 |
Эбботт Лэборетриз (Us) |
Иммуноглобулины с двумя вариабельными доменами и их применение
|
US9109026B2
(en)
|
2008-06-03 |
2015-08-18 |
Abbvie, Inc. |
Dual variable domain immunoglobulins and uses thereof
|
MX2010014574A
(es)
|
2008-07-08 |
2011-04-27 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual para prostaglandina e2 y usos de las mismas.
|
BRPI0915825A2
(pt)
|
2008-07-08 |
2015-11-03 |
Abbott Lab |
proteínas de ligação à prostaglandina e2 usos das mesmas
|
US8067339B2
(en)
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
EP2331701B1
(de)
|
2008-08-08 |
2013-03-20 |
Vib Vzw |
Glykoproteine mit veränderten glykosylierungsmustern produzierende zellen und verfahren und verwendung davon
|
AU2009282228A1
(en)
|
2008-08-12 |
2010-02-18 |
Glycofi, Inc. |
Improved vectors and yeast strains for protein production: Ca2+ ATPase overexpression
|
US20100120701A1
(en)
|
2008-09-25 |
2010-05-13 |
Glycosyn, Inc. |
Compositions and Methods For Engineering Probiotic Yeast
|
KR20110063650A
(ko)
|
2008-10-01 |
2011-06-13 |
아사히 가라스 가부시키가이샤 |
숙주, 형질 전환체 및 그 제조 방법, 그리고 o-글리코사이드형 당 사슬 함유 이종 단백질의 제조 방법
|
US20110293605A1
(en)
|
2008-11-12 |
2011-12-01 |
Hasige Sathish |
Antibody formulation
|
US20100233079A1
(en)
*
|
2008-12-04 |
2010-09-16 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
SG171814A1
(en)
|
2008-12-19 |
2011-07-28 |
Jennewein Biotechnologie Gmbh |
Synthesis of fucosylated compounds
|
AU2009327435A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Momenta Pharmaceuticals, Inc. |
Methods related to modified glycans
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
US20110165063A1
(en)
*
|
2009-01-29 |
2011-07-07 |
Abbott Laboratories |
Il-1 binding proteins
|
BRPI1007371A2
(pt)
*
|
2009-01-29 |
2018-03-27 |
Abbott Lab |
proteínas de ligação a il-1
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
JP2012518419A
(ja)
|
2009-02-25 |
2012-08-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖操作酵母ピチア・パストリスにおけるガラクトース同化経路の代謝操作
|
TWI541021B
(zh)
|
2009-03-05 |
2016-07-11 |
艾伯維有限公司 |
Il-17結合蛋白
|
CA2753995A1
(en)
|
2009-03-06 |
2010-09-10 |
Kalobios Pharmaceuticals, Inc. |
Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3
|
US8283162B2
(en)
|
2009-03-10 |
2012-10-09 |
Abbott Laboratories |
Antibodies relating to PIVKAII and uses thereof
|
AU2010225930B2
(en)
*
|
2009-03-16 |
2017-01-12 |
Dsm Ip Assets B.V. |
Protein production in microorganisms of the phylum Labyrinthulomycota
|
BRPI1009460A2
(pt)
|
2009-03-16 |
2016-03-01 |
Cephalon Australia Pty Ltd |
domínio de ligação do anticorpo, anticorpo, uso de um domínio de ligação ou anticorpo, método para detectar a presença de células cancerígenas em uma amostra.
|
EP2424894A1
(de)
|
2009-04-27 |
2012-03-07 |
Novartis AG |
Zusammensetzungen und verfahhren zur anwendung von für die beta1-untereinheit des il-12-rezeptors spezifischen antikörpern
|
EP3275900A1
(de)
|
2009-04-27 |
2018-01-31 |
Novartis AG |
Zusammensetzungen und verfahren zur förderung des muskelwachstums
|
US20120329709A1
(en)
*
|
2009-05-26 |
2012-12-27 |
Brian Edward Collins |
Production of glycoproteins
|
WO2010138184A2
(en)
*
|
2009-05-27 |
2010-12-02 |
Synageva Biopharma Corp. |
Avian derived antibodies
|
US20120121630A1
(en)
*
|
2009-07-24 |
2012-05-17 |
Bryan Janine T |
Recombinant ectodomain expression of herpes simplex virus glycoproteins in yeast
|
CN105131112A
(zh)
|
2009-08-29 |
2015-12-09 |
Abbvie公司 |
治疗用dll4结合蛋白
|
WO2011028811A2
(en)
|
2009-09-01 |
2011-03-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
WO2011029823A1
(en)
|
2009-09-09 |
2011-03-17 |
Novartis Ag |
Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
|
CN104651428A
(zh)
|
2009-09-29 |
2015-05-27 |
根特大学 |
水解甘露糖-1-磷酸-6-甘露糖连接为磷酸-6-甘露糖
|
PL2488554T3
(pl)
|
2009-10-14 |
2020-03-31 |
Humanigen, Inc. |
Przeciwciała przeciw epha3
|
CN102666875A
(zh)
|
2009-10-15 |
2012-09-12 |
雅培制药有限公司 |
双重可变结构域免疫球蛋白及其用途
|
CA2776392A1
(en)
|
2009-10-16 |
2011-04-21 |
Merck Sharp & Dohme Corp. |
Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
|
UY32979A
(es)
*
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
EP2494030A4
(de)
|
2009-10-30 |
2013-03-27 |
Merck Sharp & Dohme |
Verfahren zur herstellung therapeutischer proteine in pichia pastoris ohne dipeptidyl-aminopeptidase-aktivität
|
WO2011053545A1
(en)
*
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris
|
WO2011051327A2
(en)
|
2009-10-30 |
2011-05-05 |
Novartis Ag |
Small antibody-like single chain proteins
|
AU2010313608A1
(en)
|
2009-10-30 |
2012-06-07 |
Merck Sharp & Dohme Corp. |
Methods for the production of recombinant proteins with improved secretion efficiencies
|
US8420083B2
(en)
*
|
2009-10-31 |
2013-04-16 |
Abbvie Inc. |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
WO2011051466A1
(en)
|
2009-11-02 |
2011-05-05 |
Novartis Ag |
Anti-idiotypic fibronectin-based binding molecules and uses thereof
|
EP2496257A4
(de)
|
2009-11-05 |
2013-02-27 |
Cephalon Australia Pty Ltd |
Behandlung von krebs mit mutierten kras- oder braf-genen
|
JP2013511272A
(ja)
|
2009-11-19 |
2013-04-04 |
オキシレイン ユーケー リミテッド |
哺乳類様複合n−グリカンを生成する酵母株
|
US8722615B2
(en)
|
2009-12-02 |
2014-05-13 |
Acceleron Pharma, Inc. |
Compositions and methods for increasing serum half-life
|
AU2010329955A1
(en)
|
2009-12-08 |
2012-05-24 |
Abbott Gmbh & Co. Kg |
Monoclonal antibodies against the RGM A protein for use in the treatment of retinal nerve fiber layer degeneration
|
MX2012007318A
(es)
|
2009-12-22 |
2012-07-20 |
Novartis Ag |
Proteina de fusion de la region constante del anticuerpo-cd47 tetravalente para usarse en terapia.
|
AU2010339544B2
(en)
*
|
2009-12-28 |
2015-11-12 |
Merial Limited |
Production of hemagglutinin-neuraminidase protein in microalgae
|
WO2011090730A1
(en)
*
|
2009-12-28 |
2011-07-28 |
Martek Biosciences Corporation |
Recombinant thraustochytrids that grow on xylose, and compositions, methods of making, and uses thereof
|
EP2519635B1
(de)
*
|
2009-12-28 |
2018-11-21 |
Sanofi Vaccine Technologies, S.A.S. |
Herstellung heterologer polypeptide in mikroalgen, extrazelluläre algenkörper, zusammensetzungen und verfahren zur herstellung sowie verwendungen davon
|
WO2011092233A1
(en)
|
2010-01-29 |
2011-08-04 |
Novartis Ag |
Yeast mating to produce high-affinity combinations of fibronectin-based binders
|
US8715963B2
(en)
*
|
2010-02-24 |
2014-05-06 |
Merck Sharp & Dohme Corp. |
Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris
|
KR20180044441A
(ko)
|
2010-03-02 |
2018-05-02 |
애브비 인코포레이티드 |
치료학적 dll4 결합 단백질
|
CN102869784A
(zh)
|
2010-04-07 |
2013-01-09 |
动量制药公司 |
高甘露糖聚糖
|
WO2011130377A2
(en)
|
2010-04-15 |
2011-10-20 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
WO2011139714A2
(en)
|
2010-04-26 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
|
CN103096911B
(zh)
|
2010-04-27 |
2018-05-29 |
Atyr 医药公司 |
与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
WO2011139853A2
(en)
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
WO2011150279A2
(en)
|
2010-05-27 |
2011-12-01 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
AU2011248457B2
(en)
|
2010-04-29 |
2017-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
|
CN103097523B
(zh)
|
2010-04-29 |
2016-09-28 |
Atyr医药公司 |
与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
US8981045B2
(en)
|
2010-05-03 |
2015-03-17 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
|
US8961961B2
(en)
|
2010-05-03 |
2015-02-24 |
a Tyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
|
CN105820252B
(zh)
|
2010-05-03 |
2020-07-21 |
Atyr 医药公司 |
与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CA2798139C
(en)
|
2010-05-04 |
2019-09-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
CN103200953B
(zh)
|
2010-05-14 |
2017-02-15 |
Atyr 医药公司 |
与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
LT2571532T
(lt)
|
2010-05-14 |
2017-08-10 |
Abbvie Inc. |
Il-1 surišantys baltymai
|
JP5956982B2
(ja)
|
2010-05-27 |
2016-07-27 |
メルク・シャープ・エンド・ドーム・コーポレイション |
改善された特性を有する抗体の製造方法
|
EP2575857B1
(de)
|
2010-06-01 |
2018-01-24 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von lysyl-trna-synthetasen
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
AU2011289831C1
(en)
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
WO2012013823A2
(en)
*
|
2010-07-30 |
2012-02-02 |
Glycode |
A yeast artificial chromosome carrying the mammalian glycosylation pathway
|
PE20131412A1
(es)
|
2010-08-03 |
2014-01-19 |
Abbvie Inc |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
AU2011288412A1
(en)
|
2010-08-13 |
2013-02-21 |
Medimmune Limited |
Monomeric polypeptides comprising variant Fc regions and methods of use
|
CA2808187A1
(en)
|
2010-08-14 |
2012-02-23 |
Abbvie Inc. |
Amyloid-beta binding proteins
|
WO2012022734A2
(en)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anti-icam-1 antibodies and methods of use
|
PT3333188T
(pt)
|
2010-08-19 |
2022-03-28 |
Zoetis Belgium S A |
Anticorpos de anti-ngf e a sua utilização
|
CN103108650A
(zh)
|
2010-08-25 |
2013-05-15 |
Atyr医药公司 |
与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
TW201211252A
(en)
|
2010-08-26 |
2012-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
WO2012042387A2
(en)
|
2010-09-29 |
2012-04-05 |
Oxyrane Uk Limited |
De-mannosylation of phosphorylated n-glycans
|
WO2012042386A2
(en)
|
2010-09-29 |
2012-04-05 |
Oxyrane Uk Limited |
Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
|
JP2013543384A
(ja)
|
2010-10-05 |
2013-12-05 |
ノバルティス アーゲー |
抗−il12rベータ1抗体ならびに自己免疫性および炎症性疾患の処置おけるその使用
|
EP2646606B1
(de)
|
2010-12-01 |
2018-10-10 |
Merck Sharp&Dohme Corp. |
Oberflächen-verankertes fc-beute-antikörperanzeigesystem
|
WO2012076670A2
(en)
|
2010-12-10 |
2012-06-14 |
Novartis Ag |
Antibody formulation
|
PE20141060A1
(es)
|
2010-12-21 |
2014-09-26 |
Abbvie Inc |
Inmunoglobulinas de dominio variable dual biespecificas de il-1 alfa y beta y su uso
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
CN103443285B9
(zh)
|
2011-02-08 |
2018-04-24 |
米迪缪尼有限公司 |
特异性结合金黄色葡萄球菌α毒素的抗体以及使用方法
|
JP2014518608A
(ja)
|
2011-02-25 |
2014-08-07 |
メルク・シャープ・アンド・ドーム・コーポレーション |
修飾o−グリコシル化を有するタンパク質の製造のための酵母株
|
WO2012125553A2
(en)
|
2011-03-12 |
2012-09-20 |
Momenta Pharmaceuticals, Inc. |
N-acetylhexosamine-containing n-glycans in glycoprotein products
|
JP2014509864A
(ja)
|
2011-03-23 |
2014-04-24 |
グリコド |
Gdp−フコースを産生可能な酵母組換え細胞
|
EP2702077A2
(de)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen
|
DK2707391T3
(en)
|
2011-05-13 |
2018-02-05 |
Gamamabs Pharma |
ANTIBODIES AGAINST HER3
|
CA2834589A1
(en)
|
2011-05-25 |
2012-11-29 |
Merck Sharp & Dohme Corp. |
Method for preparing fc-containing polypeptides having improved properties
|
WO2012172521A1
(en)
|
2011-06-16 |
2012-12-20 |
Novartis Ag |
Soluble proteins for use as therapeutics
|
FR2976811A1
(fr)
|
2011-06-22 |
2012-12-28 |
Lfb Biotechnologies |
Utilisation d'un anticorps anti-cd20 a haute adcc pour le traitement de la maladie de waldenstrom
|
KR20140104944A
(ko)
|
2011-06-22 |
2014-08-29 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-axl 항체 및 그의 용도
|
US9409988B2
(en)
|
2011-06-22 |
2016-08-09 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-Axl antibodies and uses thereof
|
PL2726099T3
(pl)
|
2011-07-01 |
2018-12-31 |
Novartis Ag |
Sposób leczenia zaburzeń metabolicznych
|
AU2012283039A1
(en)
|
2011-07-13 |
2014-01-30 |
Abbvie Inc. |
Methods and compositions for treating asthma using anti-IL-13 antibodies
|
EP2734537B1
(de)
|
2011-07-20 |
2022-12-21 |
Zepteon, Incorporated |
Polypeptid-trennverfahren
|
US9371519B2
(en)
*
|
2011-10-03 |
2016-06-21 |
National Institute Of Advanced Industrial Science And Technology |
Complex type sugar chain hydrolase
|
TW201323440A
(zh)
|
2011-10-24 |
2013-06-16 |
Abbvie Inc |
抗骨硬化素(sclerostin)之免疫結合物
|
AR088512A1
(es)
|
2011-10-24 |
2014-06-18 |
Abbvie Inc |
Anticuerpos dirigidos contra el tnf
|
BR112014009925B1
(pt)
|
2011-10-28 |
2022-09-20 |
Teva Pharmaceuticals Australia Pty Ltd |
Construtores de polipeptídeos e seus usos
|
KR20140091018A
(ko)
|
2011-10-28 |
2014-07-18 |
머크 샤프 앤드 돔 코포레이션 |
재조합 단백질 발현을 위한 조작된 하등 진핵 숙주 균주
|
WO2013066685A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Engineered pichia strains with improved fermentation yield and n-glycosylation quality
|
US9580509B2
(en)
|
2011-11-07 |
2017-02-28 |
Medimmune, Llc |
Multispecific and multivalent binding proteins and uses thereof
|
KR101457514B1
(ko)
|
2011-11-21 |
2014-11-03 |
한국생명공학연구원 |
우렁쉥이(멍게) 유래의 시알산 전이효소 및 이를 이용한 시알화 복합당질 합성 방법
|
JP6392123B2
(ja)
|
2011-12-20 |
2018-09-19 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
糖尿病治療のためのctp系インスリンアナローグ
|
TW201333035A
(zh)
|
2011-12-30 |
2013-08-16 |
Abbvie Inc |
針對il-13及/或il-17之雙特異性結合蛋白
|
EP2617732A1
(de)
|
2012-01-19 |
2013-07-24 |
Vib Vzw |
Werkzeuge und Verfahren zur Expression von Membranproteinen
|
KR102129234B1
(ko)
|
2012-01-27 |
2020-07-02 |
아비에 도이치란트 게엠베하 운트 콤파니 카게 |
신경돌기 변성과 연관된 질환의 진단 및 치료를 위한 조성물 및 방법
|
EP3311847A1
(de)
|
2012-02-16 |
2018-04-25 |
Atyr Pharma, Inc. |
Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
|
BR112014022624A2
(pt)
|
2012-03-15 |
2017-07-11 |
Oxyrane Uk Ltd |
métodos e materiais para tratamento de doença de pompe
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
CN104271816A
(zh)
|
2012-05-11 |
2015-01-07 |
默沙东公司 |
表面锚定的轻链诱饵抗体展示系统
|
EP2852610B1
(de)
|
2012-05-23 |
2018-07-11 |
Glykos Finland Oy |
Herstellung von fucosylierten glykoproteinen
|
US9695244B2
(en)
|
2012-06-01 |
2017-07-04 |
Momenta Pharmaceuticals, Inc. |
Methods related to denosumab
|
US9617334B2
(en)
|
2012-06-06 |
2017-04-11 |
Zoetis Services Llc |
Caninized anti-NGF antibodies and methods thereof
|
US9216219B2
(en)
|
2012-06-12 |
2015-12-22 |
Novartis Ag |
Anti-BAFFR antibody formulation
|
WO2014004549A2
(en)
|
2012-06-27 |
2014-01-03 |
Amgen Inc. |
Anti-mesothelin binding proteins
|
WO2014011955A2
(en)
|
2012-07-12 |
2014-01-16 |
Abbvie, Inc. |
Il-1 binding proteins
|
AU2013291964B2
(en)
|
2012-07-18 |
2017-12-14 |
Glycotope Gmbh |
Novel therapeutic treatments with anti-HER2 antibodies having a low fucosylation
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
JOP20200308A1
(ar)
|
2012-09-07 |
2017-06-16 |
Novartis Ag |
جزيئات إرتباط il-18
|
AU2013335065B2
(en)
|
2012-10-22 |
2018-10-25 |
Merck Sharp & Dohme Llc |
CRZ1 mutant fungal cells
|
AU2013334652B2
(en)
|
2012-10-23 |
2019-02-21 |
Research Corporation Technologies, Inc. |
Pichia pastoris strains for producing predominantly homogeneous glycan structure
|
WO2014064203A1
(en)
|
2012-10-26 |
2014-05-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Lyve-1 antagonists for preventing or treating a pathological condition associated with lymphangiogenesis
|
KR20190107184A
(ko)
|
2012-11-01 |
2019-09-18 |
애브비 인코포레이티드 |
항-vegf/dll4 이원 가변 도메인 면역글로불린 및 이의 용도
|
EP2733153A1
(de)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur Herstellung von Immunkonjugaten und Verwendungen davon
|
JP6735561B2
(ja)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
O−グリコシル化カルボキシ末端部分(ctp)ペプチド系のインスリンおよびインスリン類似体
|
WO2014093240A1
(en)
|
2012-12-10 |
2014-06-19 |
The General Hospital Corporation |
Bivalent il-2 fusion toxins
|
WO2014090948A1
(en)
|
2012-12-13 |
2014-06-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serpin spn4a and biologically active derivatives thereof for use in the treatment of cancer
|
EP2931749B1
(de)
|
2012-12-17 |
2019-04-24 |
Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme |
Verwendung monoklonaler antikörper zur behandlung von entzündungen und bakteriellen infektionen
|
EP2934589B1
(de)
|
2012-12-18 |
2021-01-13 |
The Rockefeller University |
Glycanmodifizierte anti-cd4-antikörper für hiv-prävention und -therapie
|
WO2014100542A1
(en)
|
2012-12-21 |
2014-06-26 |
Abbvie, Inc. |
High-throughput antibody humanization
|
US9458244B2
(en)
|
2012-12-28 |
2016-10-04 |
Abbvie Inc. |
Single chain multivalent binding protein compositions and methods
|
WO2014106015A2
(en)
|
2012-12-28 |
2014-07-03 |
Abbvie, Inc. |
Multivalent binding protein compositions
|
WO2014111744A1
(en)
|
2013-01-16 |
2014-07-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A soluble fibroblast growth factor receptor 3 (fgr3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders
|
WO2014116596A1
(en)
|
2013-01-22 |
2014-07-31 |
Abbvie, Inc. |
Methods for optimizing domain stability of binding proteins
|
MX371052B
(es)
|
2013-02-08 |
2020-01-14 |
Novartis Ag |
Anticuerpos anti-il-17a y su uso en el tratamiento de trastornos autoinmunes e inflamatorios.
|
US9534041B2
(en)
|
2013-02-12 |
2017-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies that neutralize a norovirus
|
ES2755181T3
(es)
|
2013-02-13 |
2020-04-21 |
Lab Francais Du Fractionnement |
Anticuerpos anti-TNF-alfa altamente galactosilados y usos de los mismos
|
WO2014138188A1
(en)
|
2013-03-07 |
2014-09-12 |
The General Hospital Corporation |
Human ctla4 mutants and use thereof
|
WO2014143205A1
(en)
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
CA2902877A1
(en)
|
2013-03-13 |
2014-10-02 |
Jeffrey Boyington |
Prefusion rsv f proteins and their use
|
BR112015023071A2
(pt)
|
2013-03-14 |
2017-07-18 |
Univ Indiana Res & Tech Corp |
conjugados de insulina-incretina
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
US9499614B2
(en)
|
2013-03-14 |
2016-11-22 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
|
EP3564384A1
(de)
|
2013-03-14 |
2019-11-06 |
Abbott Laboratories |
Monoklonale antikörper gegen hcv-core lipid-bindender domäne
|
CN105228649B
(zh)
|
2013-03-14 |
2019-01-18 |
雅培制药有限公司 |
Hcv抗原-抗体组合测定和方法以及用在其中的组合物
|
US9790478B2
(en)
|
2013-03-14 |
2017-10-17 |
Abbott Laboratories |
HCV NS3 recombinant antigens and mutants thereof for improved antibody detection
|
WO2014149067A1
(en)
|
2013-03-15 |
2014-09-25 |
Momenta Pharmaceuticals, Inc. |
Methods related to ctla4-fc fusion proteins
|
BR112015023797A2
(pt)
|
2013-03-15 |
2017-10-24 |
Abbvie Inc |
proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17
|
EP3460054B1
(de)
|
2013-03-15 |
2020-10-21 |
aTyr Pharma, Inc. |
Histidyl-trna-synthetase-fc-konjugate
|
MX2015014773A
(es)
|
2013-04-22 |
2016-03-04 |
Glycotope Gmbh |
Tratamientos anti-cancer con anticuerpos anti-egfr que tienen una fucosilacion baja.
|
US11117975B2
(en)
|
2013-04-29 |
2021-09-14 |
Teva Pharmaceuticals Australia Pty Ltd |
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
|
EA033115B1
(ru)
|
2013-04-29 |
2019-08-30 |
Тева Фармасьютикалз Острэйлиа Пти Лтд. |
АНТИТЕЛА ПРОТИВ CD38 И СЛИТЫЕ БЕЛКИ С ОСЛАБЛЕННЫМ ИНТЕРФЕРОНОМ АЛЬФА-2b
|
EP2994163B1
(de)
|
2013-05-09 |
2019-08-28 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Single-domain-vhh-antikörper gegen norovirus gi.1 und gii.4 und deren verwendung
|
WO2014186310A1
(en)
|
2013-05-13 |
2014-11-20 |
Momenta Pharmaceuticals, Inc. |
Methods for the treatment of neurodegeneration
|
MX2016001969A
(es)
|
2013-08-14 |
2016-06-02 |
Novartis Ag |
Metodos para tratar la miositis por cuerpos de inclusion esporadica.
|
KR102232348B1
(ko)
|
2013-09-05 |
2021-03-29 |
브이아이비 브이지더블유 |
글리코실화 패턴이 변경된 Fc 함유 분자를 생산하는 세포 및 이의 방법 및 용도
|
WO2015044379A1
(en)
|
2013-09-27 |
2015-04-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A dyrk1a polypeptide for use in preventing or treating metabolic disorders
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
BR112016006999B1
(pt)
|
2013-10-02 |
2023-11-14 |
Medimmune, Llc |
Anticorpos neutralizantes antiinfluenza a seus usos, seu método de produção, composição que os compreendem, ácido nucleico e vetor
|
WO2015051293A2
(en)
|
2013-10-04 |
2015-04-09 |
Abbvie, Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
WO2015057622A1
(en)
|
2013-10-16 |
2015-04-23 |
Momenta Pharmaceuticals, Inc. |
Sialylated glycoproteins
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
ES2759252T3
(es)
|
2013-10-31 |
2020-05-08 |
Resolve Therapeutics Llc |
Fusiones y métodos terapéuticos de nucleasa-albúmina
|
ES2865196T3
(es)
|
2013-11-07 |
2021-10-15 |
Inst Nat Sante Rech Med |
Anticuerpos anti-HER3 humana alostéricos de neuregulina
|
WO2015073884A2
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
FR3016633B1
(fr)
|
2014-01-17 |
2018-04-13 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Immunoglobuline anti-toxine du charbon
|
EP3495482B1
(de)
|
2014-01-21 |
2020-09-02 |
Synplogen Co., Ltd. |
Verfahren zur vorbereitung einer dna-einheit-zusammensetzung und verfahren zur erzeugung von verketteter dna
|
TW202214691A
(zh)
|
2014-03-21 |
2022-04-16 |
美商艾伯維有限公司 |
抗-egfr抗體及抗體藥物結合物
|
TW201622746A
(zh)
|
2014-04-24 |
2016-07-01 |
諾華公司 |
改善或加速髖部骨折術後身體復原之方法
|
UA119352C2
(uk)
|
2014-05-01 |
2019-06-10 |
Тева Фармасьютикалз Острейліа Пті Лтд |
Комбінація леналідоміду або помалідоміду і конструкції анти-cd38 антитіло-атенуйований інтерферон альфа-2b та спосіб лікування суб'єкта, який має cd38-експресуючу пухлину
|
US20170291939A1
(en)
|
2014-06-25 |
2017-10-12 |
Novartis Ag |
Antibodies specific for il-17a fused to hyaluronan binding peptide tags
|
US10294292B2
(en)
|
2014-07-15 |
2019-05-21 |
Medimmune, Llc |
Neutralizing anti-influenza B antibodies and uses thereof
|
US10513724B2
(en)
|
2014-07-21 |
2019-12-24 |
Glykos Finland Oy |
Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
|
JO3663B1
(ar)
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
|
UA122395C2
(uk)
|
2014-08-19 |
2020-11-10 |
Мерк Шарп Енд Доум Корп. |
Антитіло проти tigit
|
US10232020B2
(en)
|
2014-09-24 |
2019-03-19 |
Indiana University Research And Technology Corporation |
Incretin-insulin conjugates
|
WO2016050867A1
(en)
|
2014-10-01 |
2016-04-07 |
Medimmune Limited |
Antibodies to ticagrelor and methods of use
|
CN107106656A
(zh)
|
2014-10-29 |
2017-08-29 |
梯瓦制药澳大利亚股份有限公司 |
干扰素α2b变体
|
WO2016069889A1
(en)
|
2014-10-31 |
2016-05-06 |
Resolve Therapeutics, Llc |
Therapeutic nuclease-transferrin fusions and methods
|
US11518797B2
(en)
|
2014-11-11 |
2022-12-06 |
Clara Foods Co. |
Methods and compositions for egg white protein production
|
WO2016090170A1
(en)
|
2014-12-05 |
2016-06-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
A potent anti-influenza a neuraminidase subtype n1 antibody
|
US10398774B2
(en)
|
2014-12-09 |
2019-09-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies against AXL
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
WO2016160976A2
(en)
|
2015-03-30 |
2016-10-06 |
Abbvie Inc. |
Monovalent tnf binding proteins
|
EP3091033A1
(de)
|
2015-05-06 |
2016-11-09 |
Gamamabs Pharma |
Anti-human-her3-antikörper und verwendungen davon
|
TWI820377B
(zh)
|
2015-05-07 |
2023-11-01 |
美商艾吉納斯公司 |
抗ox40抗體及其使用方法
|
JP6770533B2
(ja)
|
2015-05-22 |
2020-10-14 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Cath−Dの触媒活性と、そのLRP1レセプターへの結合との両方を阻害するヒトモノクローナル抗体フラグメント
|
RU2715597C2
(ru)
|
2015-05-29 |
2020-03-02 |
Эббви Инк. |
Антитела к cd40 и способы их применения
|
MX2017015189A
(es)
|
2015-06-01 |
2018-04-13 |
Medimmune Llc |
Neutralizacion de moleculas de union anti-influenza y usos de las mismas.
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
FR3038517B1
(fr)
|
2015-07-06 |
2020-02-28 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Utilisation de fragments fc modifies en immunotherapie
|
AU2016290670B2
(en)
|
2015-07-09 |
2020-11-05 |
Universiteit Gent |
Cells producing glycoproteins having altered n- and o-glycosylation patterns and methods and use thereof
|
WO2017058944A1
(en)
|
2015-09-29 |
2017-04-06 |
Amgen Inc. |
Asgr inhibitors
|
RU2694903C1
(ru)
|
2015-10-12 |
2019-07-18 |
АПРОДЖЕН КейАйСи ИНК. |
Антитела к CD43 и их применение для лечения рака
|
JO3555B1
(ar)
|
2015-10-29 |
2020-07-05 |
Merck Sharp & Dohme |
جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
|
WO2017106129A1
(en)
|
2015-12-16 |
2017-06-22 |
Merck Sharp & Dohme Corp. |
Anti-lag3 antibodies and antigen-binding fragments
|
US11414477B2
(en)
|
2016-01-27 |
2022-08-16 |
Medimmune, Llc |
Methods for preparing antibodies with a defined glycosylation pattern
|
NZ743881A
(en)
|
2016-02-06 |
2023-11-24 |
Epimab Biotherapeutics Inc |
Fabs-in-tandem immunoglobulin and uses thereof
|
MA44236A
(fr)
|
2016-02-17 |
2018-12-26 |
Novartis Ag |
Anticorps anti-tgfbêta 2
|
KR102438140B1
(ko)
|
2016-03-22 |
2022-08-31 |
엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 |
인간화 항-클라우딘-1 항체 및 이의 용도
|
LT3458479T
(lt)
|
2016-06-08 |
2021-02-25 |
Abbvie Inc. |
Anti-b7-h3 antikūnai ir antikūnų vaisto konjugatai
|
JP2019521973A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗bh7−h3抗体及び抗体薬物コンジュゲート
|
BR112018075651A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-cd98 e conjugados anticorpo fármaco
|
BR112018075653A2
(pt)
|
2016-06-08 |
2019-08-27 |
Abbvie Inc |
anticorpos anti-b7-h3 e conjugados anticorpo fármaco
|
JP2019521975A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗egfr抗体薬物コンジュゲート
|
PE20190512A1
(es)
|
2016-06-08 |
2019-04-10 |
Abbvie Inc |
Conjugados de anticuerpo anti-egfr y farmaco
|
WO2017214233A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-egfr antibody drug conjugates
|
CA3027033A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
MX2018015272A
(es)
|
2016-06-08 |
2019-08-12 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
MA45554A
(fr)
|
2016-07-01 |
2019-05-08 |
Resolve Therapeutics Llc |
Fusions de binucléase optimisées.
|
CN117717604A
(zh)
|
2016-07-19 |
2024-03-19 |
梯瓦制药澳大利亚股份有限公司 |
抗cd47联合治疗
|
US11186634B2
(en)
|
2016-07-29 |
2021-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies targeting tumor associated macrophages and uses thereof
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
NL2017270B1
(en)
|
2016-08-02 |
2018-02-09 |
Aduro Biotech Holdings Europe B V |
New anti-hCTLA-4 antibodies
|
WO2018026969A2
(en)
|
2016-08-03 |
2018-02-08 |
Achaogen, Inc. |
Plazomicin antibodies and methods of use
|
TWI672317B
(zh)
|
2016-08-16 |
2019-09-21 |
英屬開曼群島商岸邁生物科技有限公司 |
單價不對稱串聯Fab雙特異性抗體
|
JP7174691B2
(ja)
|
2016-08-23 |
2022-11-17 |
メディミューン リミテッド |
抗vegf-aおよび抗ang2抗体ならびにそれらの使用
|
AU2017315076B2
(en)
|
2016-08-23 |
2020-10-08 |
Medimmune Limited |
Anti-VEGF-A antibodies and uses thereof
|
US20190270821A1
(en)
|
2016-09-13 |
2019-09-05 |
Humanigen, Inc. |
Epha3 antibodies for the treatment of pulmonary fibrosis
|
JOP20190055A1
(ar)
|
2016-09-26 |
2019-03-24 |
Merck Sharp & Dohme |
أجسام مضادة ضد cd27
|
US11186635B2
(en)
|
2016-10-25 |
2021-11-30 |
Institut National De La Santé Et De La Recherché Médical (Inserm) |
Monoclonal antibodies binding to the CD160 transmembrane isoform
|
JP7274417B2
(ja)
|
2016-11-23 |
2023-05-16 |
イミュノア・セラピューティクス・インコーポレイテッド |
4-1bb結合タンパク質及びその使用
|
CN110300599A
(zh)
|
2016-12-07 |
2019-10-01 |
艾吉纳斯公司 |
抗体和其使用方法
|
WO2018146253A1
(en)
|
2017-02-10 |
2018-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the mapk pathway
|
JP2020510432A
(ja)
|
2017-03-02 |
2020-04-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Nectin−4への特異性を有する抗体及びその使用
|
WO2018170332A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Nutech Ventures |
Extracellular vesicles and methods of using
|
CA3054837A1
(en)
|
2017-03-24 |
2018-09-27 |
Novartis Ag |
Methods for preventing and treating heart disease
|
TWI796329B
(zh)
|
2017-04-07 |
2023-03-21 |
美商默沙東有限責任公司 |
抗-ilt4抗體及抗原結合片段
|
EP3609922A2
(de)
|
2017-04-13 |
2020-02-19 |
Aduro Biotech Holdings, Europe B.V. |
Anti-sirp-alpha-antikörper
|
EP3612567A4
(de)
|
2017-04-19 |
2020-11-11 |
Bluefin Biomedicine, Inc. |
Anti-vtcn1-antikörper und antikörper-wirkstoff-konjugate
|
WO2018219956A1
(en)
|
2017-05-29 |
2018-12-06 |
Gamamabs Pharma |
Cancer-associated immunosuppression inhibitor
|
UY37758A
(es)
|
2017-06-12 |
2019-01-31 |
Novartis Ag |
Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
|
GB201710838D0
(en)
|
2017-07-05 |
2017-08-16 |
Ucl Business Plc |
Bispecific antibodies
|
US11898187B2
(en)
|
2017-08-15 |
2024-02-13 |
Northwestern University |
Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases
|
MX2020002070A
(es)
|
2017-08-22 |
2020-03-24 |
Sanabio Llc |
Receptores solubles de interferon y usos de los mismos.
|
MA49950A
(fr)
|
2017-08-25 |
2020-07-01 |
Five Prime Therapeutics Inc |
Anticorps anti-b7-h4 et leurs procédés d'utilisation
|
WO2019075090A1
(en)
|
2017-10-10 |
2019-04-18 |
Tilos Therapeutics, Inc. |
ANTI-LAP ANTIBODIES AND USES THEREOF
|
WO2019148412A1
(en)
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
CA3091174A1
(en)
|
2018-02-21 |
2019-08-29 |
Five Prime Therapeutics, Inc. |
B7-h4 antibody formulations
|
SG11202007820QA
(en)
|
2018-02-21 |
2020-09-29 |
Five Prime Therapeutics Inc |
B7-h4 antibody dosing regimens
|
WO2019169212A1
(en)
|
2018-03-02 |
2019-09-06 |
Five Prime Therapeutics, Inc. |
B7-h4 antibodies and methods of use thereof
|
MX2020009526A
(es)
|
2018-03-12 |
2020-10-28 |
Zoetis Services Llc |
Anticuerpos anti-ngf y metodos de estos.
|
US11530432B2
(en)
|
2018-03-19 |
2022-12-20 |
Northwestern University |
Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
|
WO2019204346A1
(en)
|
2018-04-16 |
2019-10-24 |
Northwestern University |
METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES
|
WO2020041483A1
(en)
*
|
2018-08-21 |
2020-02-27 |
Clara Foods Co. |
Modification of protein glycosylation in microorganisms
|
CN112672760A
(zh)
|
2018-09-13 |
2021-04-16 |
德克萨斯大学体系董事会 |
新颖lilrb4抗体和其用途
|
EP3853251A1
(de)
|
2018-09-19 |
2021-07-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und pharmazeutische zusammensetzung zur behandlung von krebserkrankungen mit resistenz gegen immun-checkpoint-therapie
|
WO2020076969A2
(en)
|
2018-10-10 |
2020-04-16 |
Tilos Therapeutics, Inc. |
Anti-lap antibody variants and uses thereof
|
WO2020081497A1
(en)
|
2018-10-15 |
2020-04-23 |
Five Prime Therapeutics, Inc. |
Combination therapy for cancer
|
EP3877413A1
(de)
|
2018-11-06 |
2021-09-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und pharmazeutische zusammensetzungen zur behandlung von akuter myeloischer leukämie durch vernichtung von leukämischen stammzellen
|
US20220064260A1
(en)
|
2018-12-14 |
2022-03-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregs
|
CN113597319A
(zh)
|
2019-01-04 |
2021-11-02 |
分解治疗有限责任公司 |
用核酸酶融合蛋白治疗干燥症
|
WO2020148207A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies binding to hla-a2
|
WO2020234399A1
(en)
|
2019-05-20 |
2020-11-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Novel anti-cd25 antibodies
|
CR20210607A
(es)
|
2019-06-12 |
2022-01-21 |
Novartis Ag |
Anticuerpos de receptor de péptido natriurético 1 y métodos de uso
|
MX2022000374A
(es)
|
2019-07-11 |
2022-03-25 |
Clara Foods Co |
Composiciones de proteina y productos consumibles de las mismas.
|
WO2021009263A1
(en)
|
2019-07-16 |
2021-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity for cd38 and uses thereof
|
US10927360B1
(en)
|
2019-08-07 |
2021-02-23 |
Clara Foods Co. |
Compositions comprising digestive enzymes
|
US20220356234A1
(en)
|
2019-10-02 |
2022-11-10 |
Alexion Pharmaceuticals, Inc. |
Complement inhibitors for treating drug-induced complement-mediated response
|
US20220363776A1
(en)
|
2019-10-04 |
2022-11-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of ovarian cancer, breast cancer or pancreatic cancer
|
US20230040928A1
(en)
|
2019-12-09 |
2023-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to her4 and uses thereof
|
IL294936A
(en)
|
2020-01-21 |
2022-09-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Use of proteins of plant origin in tissue cultures
|
WO2021159024A1
(en)
|
2020-02-05 |
2021-08-12 |
Larimar Therapeutics, Inc. |
Tat peptide binding proteins and uses thereof
|
WO2021207449A1
(en)
|
2020-04-09 |
2021-10-14 |
Merck Sharp & Dohme Corp. |
Affinity matured anti-lap antibodies and uses thereof
|
WO2021219871A2
(en)
|
2020-04-30 |
2021-11-04 |
Aduro Biotech Holdings, Europe B.V. |
Anti-cd103 antibodies
|
JP2023525053A
(ja)
|
2020-05-12 |
2023-06-14 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
皮膚t細胞リンパ腫及びtfh由来リンパ腫を処置する新しい方法
|
WO2021233834A1
(en)
|
2020-05-17 |
2021-11-25 |
Astrazeneca Uk Limited |
Sars-cov-2 antibodies and methods of selecting and using the same
|
JP2023528535A
(ja)
|
2020-06-25 |
2023-07-04 |
メルク・シャープ・アンド・ドーム・エルエルシー |
セリン413においてリン酸化されたタウを標的化する高親和性抗体
|
CA3165342A1
(en)
|
2020-06-29 |
2022-01-06 |
James Arthur Posada |
Treatment of sjogren's syndrome with nuclease fusion proteins
|
WO2022029080A1
(en)
|
2020-08-03 |
2022-02-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Population of treg cells functionally committed to exert a regulatory activity and their use for adoptive therapy
|
WO2022034044A1
(en)
|
2020-08-10 |
2022-02-17 |
Astrazeneca Uk Limited |
Sars-cov-2 antibodies for treatment and prevention of covid-19
|
JP2024504547A
(ja)
|
2020-11-20 |
2024-02-01 |
インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル) |
抗cd25抗体
|
AR124123A1
(es)
|
2020-11-20 |
2023-02-15 |
Inst Nat Sante Rech Med |
Anticuerpos anti-cd25
|
WO2022130182A1
(en)
|
2020-12-14 |
2022-06-23 |
Novartis Ag |
Reversal binding agents for anti-natriuretic peptide receptor 1 (npr1) antibodies and uses thereof
|
JP2024503394A
(ja)
|
2021-01-08 |
2024-01-25 |
北京韓美薬品有限公司 |
4-1bbと特異的に結合する抗体及びその抗原結合フラグメント
|
EP4276113A1
(de)
|
2021-01-08 |
2023-11-15 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Spezifisch an cd47 bindender antikörper und antigenbindendes fragment davon
|
KR20230129483A
(ko)
|
2021-01-08 |
2023-09-08 |
베이징 한미 파마슈티컬 컴퍼니 리미티드 |
Pd-l1과 특이적으로 결합하는 항체 및 그 항원 결합단편
|
WO2022153212A1
(en)
|
2021-01-13 |
2022-07-21 |
Axon Neuroscience Se |
Antibodies neutralizing sars-cov-2
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
EP4313317A1
(de)
|
2021-03-23 |
2024-02-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur diagnose und behandlung von t-zelllymphomen
|
WO2022214681A1
(en)
|
2021-04-09 |
2022-10-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment of anaplastic large cell lymphoma
|
IL308134A
(en)
|
2021-06-22 |
2023-12-01 |
Novartis Ag |
BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA
|
TW202342095A
(zh)
|
2021-11-05 |
2023-11-01 |
英商阿斯特捷利康英國股份有限公司 |
用於治療和預防covid—19之組成物
|
EP4186529A1
(de)
|
2021-11-25 |
2023-05-31 |
Veraxa Biotech GmbH |
Verbesserte antikörper-nutzlast-konjugate (aps), hergestellt durch ortsspezifische konjugation mittels genetischer codeerweiterung
|
WO2023094525A1
(en)
|
2021-11-25 |
2023-06-01 |
Veraxa Biotech Gmbh |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
WO2023110937A1
(en)
|
2021-12-14 |
2023-06-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Depletion of nk cells for the treatment of adverse post-ischemic cardiac remodeling
|
WO2023144303A1
(en)
|
2022-01-31 |
2023-08-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
WO2023187657A1
(en)
|
2022-03-30 |
2023-10-05 |
Novartis Ag |
Methods of treating disorders using anti-natriuretic peptide receptor 1 (npr1) antibodies
|
WO2023198648A1
(en)
|
2022-04-11 |
2023-10-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t-cell malignancies
|
WO2023198874A1
(en)
|
2022-04-15 |
2023-10-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t cell-lymphomas
|
CN115386009B
(zh)
*
|
2022-04-26 |
2023-12-01 |
江苏靶标生物医药研究所有限公司 |
一种膜联蛋白v与血管生成抑制剂融合蛋白的构建方法和应用
|
WO2023209177A1
(en)
|
2022-04-29 |
2023-11-02 |
Astrazeneca Uk Limited |
Sars-cov-2 antibodies and methods of using the same
|
WO2023222886A1
(en)
|
2022-05-20 |
2023-11-23 |
Depth Charge Ltd |
Antibody-cytokine fusion proteins
|
WO2024003310A1
(en)
|
2022-06-30 |
2024-01-04 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of acute lymphoblastic leukemia
|
EP4309666A1
(de)
|
2022-07-21 |
2024-01-24 |
Technische Universität Dresden |
M-csf zur verwendung bei der prophylaxe und/oder behandlung viraler infektionen bei immunsuppressionszuständen
|
WO2024017998A1
(en)
|
2022-07-21 |
2024-01-25 |
Technische Universität Dresden |
M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression
|
WO2024018046A1
(en)
|
2022-07-22 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Garp as a biomarker and biotarget in t-cell malignancies
|
WO2024023283A1
(en)
|
2022-07-29 |
2024-02-01 |
Institut National de la Santé et de la Recherche Médicale |
Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
|
WO2024052503A1
(en)
|
2022-09-08 |
2024-03-14 |
Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to ltbp2 and uses thereof
|
WO2024079192A1
(en)
|
2022-10-12 |
2024-04-18 |
Institut National de la Santé et de la Recherche Médicale |
Cd81 as a biomarker and biotarget in t-cell malignancies
|
CN115590017B
(zh)
*
|
2022-11-04 |
2023-09-12 |
中国农业大学 |
一种通过降低线粒体温度提高卵母细胞冷冻效果的方法
|